相关实验视频
Updated: Jul 9, 2025

13:04
Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
Published on: March 1, 2019
8.9K
甲福明的抗糖尿病作用通过调节长非编码RNA来调节
Wenguang Chang1, Wei Li2, Peifeng Li1
1Institute for Translational Medicine, The Affiliated Hospital, College of Medicine, Qingdao University, Qingdao, China.
Frontiers in pharmacology
|December 6, 2023
概括
甲福明是一种常见的2型糖尿病 (T2D) 药物,通过调节长非编码RNAs (lncRNAs) 来发挥其降糖作用. 了解这种甲胺-lncRNA相互作用可以导致新的T2D疗法.
科学领域:
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
- 遗传学 遗传学 是一个
背景情况:
- 2型糖尿病 (T2D) 是一种复杂的代谢疾病.
- 长非编码RNAs (lncRNAs) 是生物功能的新兴调节者.
- lncRNAs与胰岛素耐药性和T2D进展有关.
研究的目的:
- 审查甲双调节T2D中的lncRNAs的机制.
- 探索甲胺的途径和目标,通过lncRNA调节进行调节.
- 突出了解二型糖尿病的甲胺-lncRNA相互作用的治疗潜力.
主要方法:
- 关于甲福明,lncRNAs和T2D的研究的文献综述.
- 对甲福明对葡萄糖代谢,炎症和胰岛素敏感性的已知影响的分析.
- 综合了当前关于metformin对lncRNA调节的研究.
主要成果:
- 甲福明的抗糖尿病作用越来越多地与lncRNA调节有关.
- 甲福林调节的lncRNAs影响葡萄糖生成,脂质代谢和炎症.
- 通过 lncRNAs 确定metformin 影响的特定途径和点.
结论:
- 甲福明在T2D中的作用机制涉及显著的lncRNA调制.
- 针对 lncRNAs 为开发新型T2D治疗提供了一个有希望的途径.
- 对甲胺-lncRNA相互作用的进一步研究对于未来的药物开发至关重要.
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Oral Hypoglycemic Agents: Biguanides and Glitazones
209
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
209
Types of RNA
63.8K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.8K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Riboswitches
8.1K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.1K

